Abstract
SCHWARTZ et al. observed that certain commercially obtainable hæmatoporphyrin preparations were contaminated by a porphyrin capable of becoming localized in experimental tumours1,2, and that pure hæmatoporphyrin was unable to do so. These findings gave the impetus to the present work on halogenoporphyrins. The premise on the basis of which halogenoporphyrins were chosen was the assumption that the aforementioned impurity represents an intermediate formed in the course of the synthesis of hæmatoporphyrin from hæmin. One such intermediate could be bis-(2-bromo-ethyl)deuteroporphyrin. Since iodine–131 is a more convenient isotope for the purpose of labelling than isotopes of bromine, the iodine 131–labelled analogue was synthesized.
Similar content being viewed by others
Article PDF
References
Schwartz, S., Absolon, K., and Vermund, H., Univ. Minn. Med. Bull., 27 (Oct. 15, 1955).
“Progress thru Research”, 1956 (General Mills Inc., Minneapolis, Minn.).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ALTMAN, K., SALOMON, K. Localization of a Halogenated Porphyrin in Mouse Tumours. Nature 187, 1124 (1960). https://doi.org/10.1038/1871124a0
Issue Date:
DOI: https://doi.org/10.1038/1871124a0
This article is cited by
-
Radiolabeled TPP with 166Dy/166Ho in vivo generator as a novel therapeutic agent
Journal of Radioanalytical and Nuclear Chemistry (2020)
-
Preparation, molecular modeling and biodistribution of 99mTc-phytochlorin complex
Journal of Radioanalytical and Nuclear Chemistry (2014)
-
Hematoporphyrin IX
Pharmaceutical Chemistry Journal (1977)
-
Metabolic studies on the accumulation of tetraphenylporphinesulfonate in tumors
Experientia (1967)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.